$48.75 $3.62 (8.0%)

04:00 PM EST on 12/10/19

Axsome Therapeutics, Inc. (NASDAQ:AXSM)

CAPS Rating: 2 out of 5

Current Price $48.75 Mkt Cap $1.6B
Open $45.46 P/E Ratio 0.00
Prev. Close $45.13 Div. (Yield) $0.00 (0.0%)
Daily Range $45.46 - $49.30 Volume 1,585,983
52-Wk Range $2.52 - $49.30 Avg. Daily Vol. 1,033,780

Caps

How do you think NASDAQ:AXSM will perform against the market?

Add Stock to CAPS Watchlist

All Players

33 Outperform
18 Underperform
 

All-Star Players

8 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AXSM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

SmartAce (99.97)
Submitted December 26, 2018

Sometimes, during the movie previews, I'll turn to the stranger sitting next to me and whisper, "We should really go see that together."

NASDAQ:AXSM VS S&P 500 (SPY)

NASDAQ:AXSM Summary

Fools bullish on NASDAQ:AXSM are also bullish on:

Fools bearish on NASDAQ:AXSM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AXSM.

Recs

0
Member Avatar TMFang4apples (76.23) Submitted: 5/9/2019 3:29:50 PM : Outperform Start Price: $9.03 NASDAQ:AXSM Score: +426.65

So simple you'll want to smack your head for not thinking about it already.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 4/26/2019 9:18:35 PM : Outperform Start Price: $16.90 NASDAQ:AXSM Score: +181.68

Bars Charts Top 100

Recs

0
Member Avatar TMFBlacknGold (95.66) Submitted: 3/25/2019 4:22:14 PM : Outperform Start Price: $8.41 NASDAQ:AXSM Score: +460.52

If it works, then AXS-05 could have some notable advantages (oral, simple components) on the market. From 01/15/2019:

"The company reported that its lead drug candidate, AXS-05, met its primary endpoint in a phase 2 trial evaluating its potential to treat major depressive disorder (MDD). The drug candidate is actually a combination of two drug compounds: the cough suppressant dextromethorphan and the depression drug bupropion. Believe it or not, the cough suppressant is the more active compound in this case, while bupropion works to increase its availability in your body. The science supporting the thesis is pretty simple and solid."

https://www.fool.com/investing/2019/01/15/3-small-cap-stocks-with-big-cap-potential.aspx

Leaderboard

Find the members with the highest scoring picks in AXSM.

Score Leader

jeepdrew222

jeepdrew222 (69.75) Score: +1,766.50

The Score Leader is the player with the highest score across all their picks in AXSM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jeepdrew222 69.75 8/27/2018 Outperform 5Y $2.60 +1,775.00% +8.50% +1,766.50 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 < 20 2/9/2018 Outperform 5Y $2.60 +1,775.00% +20.17% +1,754.83 0 Comment
NextGenStock < 20 6/20/2018 Outperform 5Y $3.00 +1,525.00% +13.44% +1,511.56 0 Comment
NateVDM214 < 20 6/21/2018 Outperform 3Y $3.15 +1,447.62% +13.57% +1,434.05 0 Comment
jumbofaceplate 37.62 5/15/2017 Outperform 5Y $4.10 +1,089.02% +30.88% +1,058.15 0 Comment
ababrmon 91.38 1/2/2018 Outperform 5Y $5.47 +791.42% +16.82% +774.60 0 Comment
warmwind < 20 1/13/2017 Outperform 5Y $5.50 +786.36% +38.23% +748.13 0 Comment
clangmead 38.18 1/15/2019 Outperform 5Y $7.52 +548.27% +21.56% +526.71 0 Comment
redfox18 99.91 1/9/2019 Outperform 5Y $7.93 +514.75% +21.37% +493.38 0 Comment
Momentum21 79.38 6/2/2016 Outperform 5Y $7.68 +534.77% +49.07% +485.70 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AXSM.